View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

MacroGenics to Participate in Upcoming Investor Conferences

MacroGenics to Participate in Upcoming Investor Conferences ROCKVILLE, MD, Feb. 26, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that the Company’s management team will participate in the following investor conferences in March: TD Cowen 46th Annual Health Care Conference (Boston, MA). MacroGenics’ President and CEO, Eric Risser, will participate in a hybrid presentation and fireside chat on Tuesday, March 3, at 3:10 pm ET. MacroGenics’ manag...

 PRESS RELEASE

Compass Diversified Reports Fourth Quarter and Full Year 2025 Financia...

Compass Diversified Reports Fourth Quarter and Full Year 2025 Financial Results WESTPORT, Conn., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle-market businesses, announced today its consolidated operating results for the three months and full year ended December 31, 2025. “2025 was a challenging year as we navigated the Lugano investigation and completed the related restatement. Despite this, our operating companies, excluding Lugano, delivered solid performance in 2025, reflecting the strength of our diversified ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

MacroGenics Announces Pausing of Enrollment of New Study Participants ...

MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial FDA has placed partial clinical hold on LINNET study of lorigerlimab in gynecologic cancer ROCKVILLE, MD, Feb. 23, 2026 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that the U. S. Food and Drug Administration (FDA) has placed a partial clinical hold on its Phase 2 LINNET study of lorigerlimab, an investigational, bispecific DART® molecule that ta...

 PRESS RELEASE

Compass Diversified Announces Appointment of Eric Weis as President of...

Compass Diversified Announces Appointment of Eric Weis as President of PrimaLoft; Elevation of Shawn Neville to PrimaLoft Board Chair WESTPORT, Conn., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI”), an owner of leading middle market businesses, today announced the appointment of Eric Weis as President of its subsidiary, PrimaLoft Inc. (“PrimaLoft”). Mr. Weis will succeed Anne Cassava who will step down as CEO of PrimaLoft effective February 23, 2026. In addition, Shawn Neville, Chief Executive Officer of BOA Technology, Inc (“BOA”) and a current member of the ...

 PRESS RELEASE

Compass Diversified Subsidiary The Honey Pot Co. Announces Appointment...

Compass Diversified Subsidiary The Honey Pot Co. Announces Appointment of Janis Smith-Gomez as Chair of the Board WESTPORT, Conn., Feb. 19, 2026 (GLOBE NEWSWIRE) -- The Honey Pot Company, LLC (“The Honey Pot Co.” or “the Company”), a leading “better-for-you” feminine care brand and subsidiary of Compass Diversified (NYSE: CODI) (“CODI”), announces the appointment of Janis Smith-Gomez as Chair of its Board of Directors, effective January 1, 2026. Ms. Smith-Gomez joined the Company’s Board in April 2024 and has brought commercial and marketing expertise developed through leadership roles a...

 PRESS RELEASE

Compass Diversified Announces Fourth Quarter and Full Year 2025 Earnin...

Compass Diversified Announces Fourth Quarter and Full Year 2025 Earnings and Conference Call Information WESTPORT, Conn., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle-market branded consumer and industrial businesses, announced today that it plans to report financial results for the fourth quarter and full year ended December 31, 2025 on Thursday, February 26, 2026 after market close. The Company has scheduled a conference call at 5:00 p.m. ET on February 26, 2026 to review its fourth quarter and full year financi...

Coty Inc.: Update following outlook change to negative

Our credit view of this issuer reflects its product offerings across mass and prestige, constrained by its concentration in more discretionary fragrance and color cosmetics categories.

Moody's Ratings affirms Coty's Ba1 CFR; outlook changed to negative

Moody's Ratings (Moody's) today affirmed Coty Inc.'s ("Coty") Ba1 Corporate Family Rating ("CFR"), Ba1-PD Probability of Default Rating, Ba1 senior secured first lien revolving credit facility rating, Ba1 senior secured ratings, and Ba1 senior unsecured ratings. Coty's SGL-2 speculative grade liquid...

David Nierengarten ... (+3)
  • David Nierengarten
  • Dennis Pak
  • Martin Fan

Compass Group Diversified Holdings LLC: Update following conclusion of...

Our credit view of this issuer reflects its high financial leverage and large debt.

 PRESS RELEASE

Altor Completes Sale-Leaseback Transaction Generating Approximately $1...

Altor Completes Sale-Leaseback Transaction Generating Approximately $11 Million in Proceeds WESTPORT, Conn., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI”) today announced that its subsidiary, Altor Solutions (“Altor”), a leading designer and manufacturer of custom protective and cold-chain packaging solutions for the industrial and life sciences markets, completed a sale-leaseback transaction involving certain Altor-owned real estate assets, generating approximately $11 million in immediately-available cash proceeds. Altor will continue to operate at the fac...

Moody's Ratings downgrades CODI's CFR to B3, concluding review; outloo...

Moody's Ratings (Moody's) downgraded Compass Group Diversified Holdings LLC's  (CODI) Corporate Family Rating (CFR) to B3 from B2, Probability of Default Rating to B3-PD from B2-PD, and the rating on the senior unsecured notes to Caa1 from B3. The rating outlook is negative. Previously, the ratings ...

Wedbush Research
  • Wedbush Research
David Nierengarten ... (+3)
  • David Nierengarten
  • Dennis Pak
  • Martin Fan
 PRESS RELEASE

Compass Diversified Reports Third Quarter 2025 Financial Results

Compass Diversified Reports Third Quarter 2025 Financial Results WESTPORT, Conn., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle-market businesses, announced today its consolidated operating results for the three and nine months ended September 30, 2025 and filed its Quarterly Report on Form 10-Q for the period. “I’m pleased to report that with today’s filing we are now fully current with our SEC filings for 2025,” said Elias Sabo, Chief Executive Officer of Compass Diversified, “and we are in full compliance with ...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: January 10, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch